Turbinate Cauterization in Pediatric Patients With Nasal Obstruction
1 other identifier
interventional
110
1 country
1
Brief Summary
patients will be placed in 2 groups, with or without turbinate cautery ( a surgical method to reduce the size of the skin covered bones in the nose), at the time of adenoidectomy and tonsillectomy. It will compare the amount of nasal congestion for each group with the idea that it will be less if treated with turbinate cauterization. Assessments from baseline to 6 months post procedure will be compared between the two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 24, 2012
CompletedFirst Posted
Study publicly available on registry
September 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedAugust 19, 2021
August 1, 2021
8.3 years
September 24, 2012
August 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
# of participants with improved nasal obstruction score from baseline to 6 months
Baseline assessment compared to 6 mo post surgery. The SN-5 Nasal Obstruction and Sinonasal Quality of Life instrument tools will be used to record nasal obstruction symptom scores.
baseline and 6 months
Study Arms (2)
Turbinate Cauterization
EXPERIMENTALTurbinate Cauterization will be completed.
control
NO INTERVENTIONno turbinate cauterization
Interventions
Eligibility Criteria
You may qualify if:
- ages 3-16
- obstructive sleep apnea warranting adenotonsillectomy
- history of daytime nasal obstruction and or mouth breathing
- failed medical treatment with either oral anti-histamine or nasal steroid spray.
- turbinate hypertrophy on Physical Exam defined by \>50% obstruction
You may not qualify if:
- \<3 or \>16
- unwillingness to comply with study procedures
- congenital head and neck malformations, genetic syndromes, craniofacial anomalies
- no evidence of turbinate hypertrophy or symptoms of nasal obstruction
- pregnancy or breastfeeding
- bleeding disorders
- current therapy with coumadin or Pradaxa
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of the King's Daughters
Norfolk, Virginia, 23507, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christina Baldassari, MD
Eastern Virginia Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Pediatric Otolaryngology
Study Record Dates
First Submitted
September 24, 2012
First Posted
September 28, 2012
Study Start
August 1, 2012
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
August 19, 2021
Record last verified: 2021-08